Blood Cells, Molecules and Diseases
Blood Cells, Molecules and Diseases[edit]
Blood Cells, Molecules and Diseases is a peer-reviewed scientific journal that focuses on the study of hematology, the branch of medicine concerned with the study of blood, the blood-forming organs, and blood diseases. The journal publishes original research articles, reviews, and case reports that contribute to the understanding of the biology and pathology of blood cells and the molecular mechanisms underlying blood diseases.
Scope and Focus[edit]
The journal covers a wide range of topics within the field of hematology, including but not limited to:
- The biology and function of red blood cells, white blood cells, and platelets.
- The molecular and cellular mechanisms of hematopoiesis, the process by which blood cells are formed.
- The pathophysiology of blood disorders such as anemia, leukemia, lymphoma, and thrombocytopenia.
- The role of cytokines, growth factors, and other signaling molecules in blood cell development and disease.
- Advances in the diagnosis and treatment of blood diseases, including gene therapy and stem cell transplantation.
Editorial Policies[edit]
The journal maintains rigorous editorial standards to ensure the publication of high-quality research. Manuscripts are subjected to a thorough peer-review process by experts in the field. The editorial board consists of leading scientists and clinicians who are actively engaged in hematology research.
History[edit]
Blood Cells, Molecules and Diseases was established to provide a dedicated platform for the dissemination of research findings in the field of hematology. Over the years, it has become a respected source of information for researchers, clinicians, and students interested in the study of blood and its disorders.
Impact and Contributions[edit]
The journal has contributed significantly to the advancement of knowledge in hematology. It has published landmark studies that have enhanced the understanding of blood cell biology and the molecular basis of blood diseases. The research published in the journal has implications for the development of new diagnostic tools and therapeutic strategies.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian